These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 11899364)
1. Serum interleukin 6, plasma VEGF, serum VEGF, and VEGF platelet load in breast cancer patients. Benoy I; Salgado R; Colpaert C; Weytjens R; Vermeulen PB; Dirix LY Clin Breast Cancer; 2002 Jan; 2(4):311-5. PubMed ID: 11899364 [TBL] [Abstract][Full Text] [Related]
2. Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients. Bachelot T; Ray-Coquard I; Menetrier-Caux C; Rastkha M; Duc A; Blay JY Br J Cancer; 2003 Jun; 88(11):1721-6. PubMed ID: 12771987 [TBL] [Abstract][Full Text] [Related]
3. Platelet number and interleukin-6 correlate with VEGF but not with bFGF serum levels of advanced cancer patients. Salgado R; Vermeulen PB; Benoy I; Weytjens R; Huget P; Van Marck E; Dirix LY Br J Cancer; 1999 May; 80(5-6):892-7. PubMed ID: 10360671 [TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease. Kraft A; Weindel K; Ochs A; Marth C; Zmija J; Schumacher P; Unger C; Marmé D; Gastl G Cancer; 1999 Jan; 85(1):178-87. PubMed ID: 9921991 [TBL] [Abstract][Full Text] [Related]
5. Clinical usefulness of serum and plasma vascular endothelial growth factor in cancer patients: which is the optimal specimen? Lee JK; Hong YJ; Han CJ; Hwang DY; Hong SI Int J Oncol; 2000 Jul; 17(1):149-52. PubMed ID: 10853032 [TBL] [Abstract][Full Text] [Related]
6. Correlation of plasma and serum vascular endothelial growth factor levels with platelet count in colorectal cancer: clinical evidence of platelet scavenging? George ML; Eccles SA; Tutton MG; Abulafi AM; Swift RI Clin Cancer Res; 2000 Aug; 6(8):3147-52. PubMed ID: 10955796 [TBL] [Abstract][Full Text] [Related]
7. Serum VEGF levels in women with a benign breast tumor or breast cancer. Salven P; Perhoniemi V; Tykkä H; Mäenpää H; Joensuu H Breast Cancer Res Treat; 1999 Jan; 53(2):161-6. PubMed ID: 10326793 [TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor (VEGF) in breast cancer: comparison of plasma, serum, and tissue VEGF and microvessel density and effects of tamoxifen. Adams J; Carder PJ; Downey S; Forbes MA; MacLennan K; Allgar V; Kaufman S; Hallam S; Bicknell R; Walker JJ; Cairnduff F; Selby PJ; Perren TJ; Lansdown M; Banks RE Cancer Res; 2000 Jun; 60(11):2898-905. PubMed ID: 10850435 [TBL] [Abstract][Full Text] [Related]
9. The clinical relevance of serum vascular endothelial growth factor (VEGF) in correlation to circulating tumor cells and other serum biomarkers in patients with metastatic breast cancer. Banys-Paluchowski M; Witzel I; Riethdorf S; Pantel K; Rack B; Janni W; Fasching PA; Aktas B; Kasimir-Bauer S; Hartkopf A; Solomayer EF; Fehm T; Müller V Breast Cancer Res Treat; 2018 Nov; 172(1):93-104. PubMed ID: 30003393 [TBL] [Abstract][Full Text] [Related]
10. Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma? Dosquet C; Coudert MC; Lepage E; Cabane J; Richard F Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2451-8. PubMed ID: 9815646 [TBL] [Abstract][Full Text] [Related]
11. Determination of vascular endothelial growth factor (VEGF) in circulating blood: significance of VEGF in various leucocytes and platelets. Werther K; Christensen IJ; Nielsen HJ Scand J Clin Lab Invest; 2002; 62(5):343-50. PubMed ID: 12387579 [TBL] [Abstract][Full Text] [Related]
12. Leukocytes and platelets of patients with cancer contain high levels of vascular endothelial growth factor. Salven P; Orpana A; Joensuu H Clin Cancer Res; 1999 Mar; 5(3):487-91. PubMed ID: 10100697 [TBL] [Abstract][Full Text] [Related]
13. Soluble vascular endothelial growth factor in various blood transfusion components. Nielsen HJ; Werther K; Mynster T; Brünner N Transfusion; 1999 Oct; 39(10):1078-83. PubMed ID: 10532601 [TBL] [Abstract][Full Text] [Related]
14. Soluble vascular endothelial growth factor levels in patients with primary colorectal carcinoma. The Danish RANX05 Colorectal Cancer Study Group. Werther K; Christensen IJ; Brünner N; Nielsen HJ Eur J Surg Oncol; 2000 Nov; 26(7):657-62. PubMed ID: 11078612 [TBL] [Abstract][Full Text] [Related]
16. [Association between elevated serum VEGF and polarographically measured tumor hypoxia in head and neck carcinomas]. Becker A; Stadler P; Krause U; Utzig D; Hänsgen G; Lautenschläger C; Rath FW; Molls M; Dunst J Strahlenther Onkol; 2001 Apr; 177(4):182-8. PubMed ID: 11370552 [TBL] [Abstract][Full Text] [Related]
17. Serum vascular endothelial growth factor is often elevated in disseminated cancer. Salven P; Mänpää H; Orpana A; Alitalo K; Joensuu H Clin Cancer Res; 1997 May; 3(5):647-51. PubMed ID: 9815732 [TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of matched preoperative plasma and serum VEGF in patients with primary colorectal carcinoma. Werther K; Christensen IJ; Nielsen HJ; Br J Cancer; 2002 Feb; 86(3):417-23. PubMed ID: 11875709 [TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor in the serum of patients with non-small cell lung cancer: correlation with platelet and leukocyte counts. Choi JH; Kim HC; Lim HY; Nam DK; Kim HS; Yi JW; Chun M; Oh YT; Kang S; Park KJ; Hwang SC; Lee YH; Hahn MH Lung Cancer; 2001; 33(2-3):171-9. PubMed ID: 11551412 [TBL] [Abstract][Full Text] [Related]
20. Plasma levels of vascular endothelial growth factor are increased in patients with metastatic prostate cancer. Duque JL; Loughlin KR; Adam RM; Kantoff PW; Zurakowski D; Freeman MR Urology; 1999 Sep; 54(3):523-7. PubMed ID: 10475365 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]